Profile: Gliknik, Inc. provides therapies for patients with cancer and autoimmune & inflammatory diseases. Our Stradobody™ platform represents a way to make antibody-mimetics, generating monoclonal antibody-like compounds that are more effective than MAbs when directed against cancer & inflammatory disease targets. Our Stradomer™ platform is a series of recombinant intravenous immunoglobulin (IVIG) mimetics, which is used in many autoimmune & inflammatory diseases that are characterized by autoantibodies and hyperaggressive T cells.